Over the past decade, various implantable devices have been developed to treat diseases that were previously difficult to manage such diabetes, chronic pain, and neurodegenerative disorders. However, translation of these novel technologies into clinical practice is often difficult because fibrotic encapsulation and/or rejection impairs device function after body implantation. Ideally, cells of the host tissue should perceive the surface of the implant being similar to the normal extracellular matrix. Here, we developed an innovative approach to provide implant surfaces with adhesive protein micropatterns. The patterns were designed to promote adhesion of fibroblasts and macrophages by simultaneously suppressing fibrogenic activation of both cell types. In a rat model, subcutaneously implanted silicone pads provided with the novel micropatterns caused 6-fold lower formation of inflammatory giant cells compared with clinical grade, uncoated, or collagen-coated silicone implants. We further show that micropatterning of implants resulted in 2e3-fold reduced numbers of pro-fibrotic myofibroblast by inhibiting their mechanical activation. Our novel approach allows controlled cell attachment to implant surfaces, representing a critical advance for enhanced biointegration of implantable medical devices.
Introduction
The number of implanted medical devices such as pacemakers, glucose sensors, and joint replacements prosthesis is steadily increasing to address the needs of an aging population. These devices dramatically improved the life of millions of patients worldwide. However, in select applications such as diabetes and support of the central nervous system, sensors for continuous monitoring and treatment of chronic conditions, clinical translation is complicated due to foreign body reactions [1e8] . Depending on the surface material, recipient site, and contact duration, implants induce fibrotic reactions that manifest clinically as scar-like capsules around the device [3] . Fibrotic encapsulation not only reduces the function and half-life of the device but can severely affect the functionality of the host tissue in critical situations such as infections, often requiring additional surgery for explantation, adding risks for the patients and increasing the costs for the health care system [9] .
To improve implant device acceptance and function by reducing foreign body and fibrotic reactions, we need to understand the mechanisms of tissueebiomaterial interactions. Several parameters have been investigated to control foreign body reactions such as functionalization with growth factors [10] . However, including such biological clues in the implant material has not yet been sufficient to guide healing for a variety of reasons. First, the release of signaling molecules must follow a precisely controlled time and concentration course in order to avoid a paradoxical down regulation of specific receptors. Second, the biophysical properties of the material is a powerful factor controlling the behavior of cells such as terminal differentiation or activation, even overriding specific actions of growth factors. Since controlling the orchestrated expression of soluble molecules in vivo is a daunting if not impossible task to date, we set out to manipulate the biophysical properties of cell interactions with the extracellular matrix (ECM) to guide cell behavior on the biomaterial surface. Our strategy principally aims in controlling the activation of host-tissue resident mesenchymal cells into myofibroblasts in the peri-prosthetic wound.
Myofibroblasts are characterized by the neo-expression of asmooth muscle actin (a-SMA) and the excessive production of collagen. It is the incorporation of a-SMA into microfilament bundles (stress fibers) that confers high cell contractile activity [11] . Myofibroblast forces are transmitted to and perceived from the ECM at sites of large, "supermature" focal adhesions (FA) that are termed 'fibronexus' in vivo [12e15] . FA mechanosensing is the basis for spontaneous myofibroblast activation upon adhesion to sufficiently rigid surfaces [11] . Since abnormal interaction of fibroblasts with implant surfaces is a possible major cause for the development of implant encapsulation, a variety of specific surface coatings have been developed to improve biointegration [3, 16] , such as adding Arg-Gly-Asp (RGD) sequences to mimic the integrin signaling domain of fibronectin. However, we hypothesize that the specific size and distribution of the adhesion sites -rather than their sheer presence in the substrate itself e is the key aspect to guide cell attachment and behavior.
Using fibroblast culture models, we have previously shown that the size of FAs is directly proportional to the level of intracellular tension and the activation state of myofibroblasts. Formation of too small FAs prevents fibroblasts to attach and survive, formation of too large FAs translates into excessive tension development and ultimately myofibroblast activation [17] . Here, we identified specific anti-fibrotic protein micro-patterns and transferred them onto silicone polymer surfaces in order to modulate celleimplant interactions. To stably transfer cell-adhesive proteins with micrometer resolution onto compliant silicone substrates, we developed an innovative stencil technology. Proteins are deposited in the desired pattern through the openings of a stencil, produced by photolithography. The principle of our novel implant surface coating procedure is applicable to most implant materials and shapes and we demonstrate that it is effective to suppress myofibroblast and inflammatory cell activation at the surface of silicone implants in cell culture and animal experiments.
Materials and methods

Cell culture and reagents
Primary rat fibroblasts were explanted from subcutaneous tissue and used between passages P2 and P5 as described before [18] and cultured in standard Dulbecco's modified Eagle's medium (DMEM; Life Technologies), supplemented with 10% fetal bovine serum (SigmaeAldrich), and penicillin/streptomycin (Life Technologies). Myofibroblast activation was induced using 2 ng/ml TGF-b1 (R&D Systems, Abington, UK) added once for 5 days to the culture medium. Murine lineage RAW 264.7 macrophages were cultured in standard medium and culture dishes. Macrophages were activated by adding LPS for 7 days to cells grown on coated/ uncoated silicone substrates.
Hard stencil production
To create a 'hard microstencil' silicon mask, exhibiting arrays of openings with characteristics of FAs at the bottom of a micro-reservoir, we used a silicon-oninsulator (SOI) 380-2-50 wafer, dry etching, and soft lithography (Fig. 1a) . Briefly, SOI wafer with the following dimensions have been used: upper silicon layer of 10 mm thickness, silicon oxide of 1 mm thickness and a lower silicon layer of 380 mm thickness. After cleaning the SOI with piranha solution, a 2 mm layer of oxide was grown by wet oxidation. This layer served as a reinforcement mask for the photoresist during the etching processes. To create the microstructure bottom side of the stencil we used a mask with small dimension holes and a 3 mm layer of AZ9260 photoresist. The mask pattern was transferred to the photoresist in a classical photolithography step. To achieve a high aspect ratio for the holes, which was recognized to be important for protein transfer, we applied an advanced dry etching Bosch process. After etching, the photoresist was removed and the wafer was turned to continue with the upper side's processing to generate the stencil reservoir. A second photolithography step was then applied, using a 10 mm layer of the photoresist AZ9260 and a second mask to produce the wide opening of the reservoir. Dry etching was again used to first remove the silicon oxide and second to etch through the thick silicon layer down to the interior oxide layer, serving to stop the etching process. Finally, photoresist and oxide layer were removed using a wet etching process to generate microstructure openings.
Pliable stencil production
To transfer proteins to curved surfaces that excluded close contact with the hard stencil, we developed an alternative method to create 'soft microstencils' (Fig. 1b) . Briefly, plasma oxygen cleaned silicon wafers were used as support to deposit a 10 mm thick layer of parylene C using a parylene deposition system (Comelec C-30-S, La Chaux-de-Fonds, Switzerland). A second layer of 500 nm amorphous silicon (a-Si) was deposed using a sputter (Pfeiffer SPIDER 600, Zürich, Switzerland), serving as support for photoresist spin-coating. A photolithography step using a mask with small dimension holes was then applied to 1 mm photoresist S1805. After development of the photoresist, we applied a dry etching of a-Si layer using a silicon etcher (Alcatel AMS 200 SE, Annecy, France) and dry etching Parylene C using (STS Multiplex ICP). As terminal step, a-Si was stripped.
Silicone implants and protein deposition
Silicone pads consisting of clinical grade silicone (Silbione LSR4305, Silitech SA, Gümligen, Germany) with dimensions 10 Â 10 Â 1 mm were either left uncoated (control, corresponding to clinically used silicones) or covalently coated with collagen type I (100 mg/ml, Devro Medical LTD, Glascow, UK), or human plasma fibronectin (FN, Sigma). To provide surfaces with a non-protein adhesive molecule, we used poly N-acetyl glucosamine (sNAG, Marine Polymer Technologies, Inc., Burlington, MA, USA). For complete coating, collagen, FN, and sNAG were covalently bound to silicone substrates, in consequent treatments with plasma oxygen, 3-aminopropyltriethoxysilane (APTES) and glutaraldehyde [19, 20] (Fig. 1c) . In brief, silicone surfaces were pre-treated with plasma oxygen (100 W, 300 mTorr, 45 s) (Tepla, Kirchheim, Germany). This layer was then covalently provided with amine groups by incubation with APTES (Sigma) (1% in water) and subsequent heating to 60 C for 60 min. Substrates were then copiously washed with PBS, immersed with 0.1% glutaraldehyde for 20 min, washed again 3-times with PBS and covalently crosslinked with collagen for 60 min at 37 C [20] . For patterning, we exposed the silicone surface to the same protein/sNAG functionalization procedure through a silicon microstencil, exhibiting arrays of openings on the bottom of a microreservoir with dimensions 2 Â 2, 4 Â 2, 6 Â 2, 8 Â 2, 10 Â 2, and 20 Â 2 mm, and regular spacing of 5 mm. The stencil was removed to leaving the protein patterned silicone (Fig. 1c) . In one series of experiments, we used polycarbonate filters (Merck Millipore, Tullagreen, Ireland) exhibiting pores with diameters of 2, 5 and 10 mm to produce irregular patterns of adhesive islands. All protein-coated surfaces were treated with PLL-g-PEG to prevent cell attachment any non-protein-coated regions (passivation) as described before [17] .
Antibodies, microscopy, and image analysis
For immunofluorescence, we used primary antibodies directed against a-SMA (aSM-1, a gift from Dr. G. Gabbiani, University of Geneva, CH), FN (Sigma), collagen type I (Acris, San Diego, CA), F4/80 (BioLegend, San Diego, CA), CD68 (Abcam, Cambridge, MA), and vinculin (hVin-1, Sigma). Primary antibodies were probed with AlexaFluor-conjugated goat anti-mouse, goat anti-rat, and goat anti-rabbit secondary antibodies (Molecular Probes, Invitrogen, Basel, CH). DNA was probed with DAPI (Sigma) and F-actin with Phalloidin-Alexa 488 (Molecular Probes) [21] . Phase contrast and epifluorescence microscopy was performed using oil immersion objectives (Plan-Neofluar 40x/1.2 Ph3, Plan-Neofluar 63x/1.4 Ph3, Zeiss) mounted on an inverted microscope (Axiovert 135, Carl Zeiss AG, Feldbach, CH) and digital CCD camera (Hamamatsu C4742-95-12ERG, Bucher Biotec AG, Basel, CH). Images were acquired with Openlab 3.1.2 software (Improvision, Basel, CH) and assembled with Adobe Photoshop CS5. To quantify the level of myofibroblast activation, the percentages of a-SMA stress fiber-positive cells of all cells were quantified in a semiautomated algorithm in Image J (U. S. National Institutes of Health (NIH), Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997e2013). Macrophage fusion into multi-nucleated giant cells was quantified by automatically detecting the number of nuclei within the boundaries of F4/80-positive single cells. To exclude that aggregates are quantified as single cells, macrophages were detached after 7 day growth on silicone surfaces, mechanically separated and reseeded onto standard plastic dishes to be quantified after another 6 h. Mean values ± standard deviation (SD) were calculated from at least three independent experiments, each comprising ten random regions of interest per experimental condition (~100 cells/field).
Animal surgery and analysis of fibrotic capsules
Adult male Wistar strain rats (300e400 g) (n ¼ 20) were fed a standard RM1 diet (Nordos, Val de Reuil, France) and given water ad libitum. Each animal was subcutaneously implanted in the dorsal region with two uncoated implants, one completely collagen coated implant, and one implant coated with arrays of 4 Â 2 mm islands, spaced 5 mm. The dimensions of the implants were 10 Â 10 Â 1 mm. Positions were randomly allocated and shifted in different animals on the dorsum of the animals. After 30 days with the implant, rats were euthanized by carbon dioxide after isoflurane anesthesia. The local ethics committee and veterinary authority approved all procedures in accordance with Swiss guidelines. Implants were excised in block with the surrounding tissue. Tissue samples were fixed in 10% neutralbuffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E) for histological analysis (Poly Scientific, Bay Shore, NY). For immunofluorescence staining of rat tissue, sections were deparaffinized in xylene, rehydrated in ethanol, and rinsed in distilled water. Antigens were revealed by boiling the slides in sodium citrate buffer (Dako, Burlington, ON) at 95e100 C for 40 min. After cooling to room temperature, sections were rinsed in PBS, blocked with 2% goat serum/1% BSA for 40 min and stained with primary and secondary antibodies.
The accumulation of multi-nucleated foreign body giant foam cells was quantified in the central zone of the capsule on basis of H&E histological staining. Masson's Trichrome staining was performed on paraffin-embedded sections to stain for collagen. Myofibroblasts were identified by staining for a-SMA as previously described [22] . Briefly, biotinylated a-SMA antibody (R&D Systems, Minneapolis, MN) was applied to slides and incubated overnight at 4 C. Activation was performed with diaminobenzidine chromogen (DAB, Dako North America Inc., Carpinteria, CA) and counterstained with H&E. Total (Masson's Trichrome) and a-SMA positive capsule thickness were quantified using image analysis (Morpho-Expert, ExploraNova, La Rochelle, France) on three different areas of the capsule from the implant interface. Regions positive for collagen (blue in Trichrome Masson's staining) or for myofibroblasts (brown in a-SMA staining) were calculated as a percentage of the whole area using Image J.
Results
Production of stencils with FA microstructure and protein deposition
Previously, we suppressed myofibroblast activation on cell culture plastic and glass surfaces by restricting the length of FAs to 6 mm, using microprinting arrays of ECM protein islets [17] .
Because microprinting of proteins is not efficient for softer silicone surfaces, e.g., such used in mammary implants, we developed a novel micro-stencil technique to generate and covalently link protein islets exhibiting FA features with lengths of 2, 4, 6, 8, 10, and 20 mm and width of 2 mm (Fig. 1) . Using photolithography, hard silicon stencils were produced with arrays of openings in the desired dimensions and spacing of 5 mm at the bottom of a reservoir (Figs. 1a, 2aef) . Pliable pyrelene stencils with the same array features were developed to apply patterns to strongly curved substrate surfaces (Figs. 1b, 2gei ). Both processes delivered stencils with bottom of a micro-reservoir, we used SOI 380-2-50 wafer, dry etching, and soft lithography. A 2 mm layer of oxide first was grown by wet oxidation, serving as a reinforcement mask for the photoresist during the etching processes. The microstructure bottom side of the stencil was created by standard photolithography using a mask with small dimension holes and a 3 mm layer of AZ9260 photoresist, followed by Bosch dry etching. The photoresist was then removed and the wafer turned to continue to generate the stencil reservoir in another photolithographic step. Finally, photoresist and oxide layer were removed using a wet etching process to generate microstructure openings. (b) Soft microstencils were designed to transfer proteins to curved surfaces. Silicon wafers were used as support to deposit a 10 mm thick layer of parylene C, followed by a second layer of 500 nm amorphous silicon (a-Si). The a-SI served as support for spin-coating of an 1 mm-thick photoresist layer and subsequent photolithography through a mask bearing the micropattern. After development of the photoresist, the a-Si and parylene layers were dry-etched and the a-Si was stripped in the terminal step. (c) For subsequent covalent binding of aminecontaining molecules (e.g., proteins and sNAG), silicone substrates were functionalized in consequent treatments using plasma oxygen, APTES and glutaraldehyde.
openings having straight vertical borders down to the 2 mm resolution (Fig. 2def, hei) .
To transfer proteins or the non-protein adhesive molecule sNAG, stencils were brought into conformal contact with silicone substrates and the stencil reservoir filled with protein/sNAG solution (Fig. 3a) . In a series of preliminary experiments, we determined that silicone surface functionalization for covalent binding of protein and sNAG in consequent treatments with plasma oxygen, APTES, and glutaraildehyde [19, 20] was pivotal for long-term stability of the coat (Fig. 1c) . After removing the stencil, non-printed regions of the hydrophobic silicone were additionally passivated against cell attachment by immersing the substrate in proteinrepellent PLL-g-PEG [17] . The resulting patterns of fluorescently labeled deposited FN (Fig. 3b, c) , collagen type I and sNAG (Fig. 3c ) accurately reproduced the printed structure. Primary rat subcutaneous fibroblasts formed vinculin-positive FAs specifically and exclusively where FN, collagen type I, and sNAG were stenciled onto the silicone in arrays of 4 Â 2 mm and 20 Â 2 mm islets (Fig. 3c) .
Identical results were obtained using pliable pyrelene stencils (unpublished data). FA formation of fibroblasts was impaired by growth on uncoated and extensive on completely coated silicones (Fig. 3c) .
Microarrays of protein islands promote fibroblast adhesion to silicone and control phenotype
We next tested the efficacy of fibroblast adhesion to silicone sample strips, stenciled with adhesion island arrays. All FN-stenciled surfaces promoted attachment of fibroblasts in the absence (Supplementary Fig. S1 ) and presence of fibroblast-activating, profibrotic TGF-b1 (Fig. 4a) . Poor adhesion and cell spreading was observed on uncoated silicone (Fig. 4a, Supplementary Fig. S1 ) (Fig. 4b) (Fig. 4b) . Cell numbers on 2 Â 2 mm islet arrays (85 ± 3 cells/mm 2 ) were low and comparable to those on uncoated silicone substrates (106 ± 7 cells/mm 2 ). On uncoated silicone substrates, fibroblasts did not spread, remained spherical, and tended to form aggregates that lifted off during the immunostaining procedure (Fig. 4a, Supplementary Fig. S1 ). To assess the effect of silicone micropatterning on fibroblast-tomyofibroblast activation, we quantified the percentage of rat subcutaneous fibroblasts expressing a-SMA in stress fibers from immunofluorescence images (Fig. 4a) . On silicone strips with complete FN coating, spontaneous myofibroblast activation was 14% ( Supplementary Fig. S1, Fig. 4c ). This fraction was significantly lower on 2 Â 2 mm and 4 Â 4 mm islet arrays (~2-fold) and uncoated substrates (~3-fold), and was similar on 10 Â 10 mm and 20 Â 20 mm patterns ( Supplementary Fig. S1, Fig. 4c) . Notably, formation of a-SMA-negative stress fibers was also reduced in cells grown on 2 Â 2 mm patterns and stress fibers were completely absent from spherical cells on uncoated substrates (Supplementary Fig. S1 ). The surface of silicone implants after surgery is exposed to an inflammatory environment containing high levels of circulating cellderived TGF-b1 [23] . Addition of TGF-b1 for 5d to the culture medium decreased cell numbers by~15% compared to the respective substrate condition in the absence of TGF-b1 (unpublished data).
TGF-b1 induced an~4-fold increase of the percentage of a-SMApositive cells on completely coated silicone, 10 Â 2 mm, and 20 Â 2 mm micropatterns (~60% a-SMA stress fiber-positive cells) compared with TGF-b1-free medium (Fig. 4a, c) . However, addition of TGF-b1 only moderately increased the percentage of a-SMA stress fiber-positive cells on 2 Â 2 mm (~20%) and 4 Â 2 mm (~30%) micropatterns (Fig. 4a, c) . Coatings produced with collagen type I and sNAG delivered similar results than FN-coated substrates with respect to cell numbers (Fig. 4d) and percentage of a-SMA-positive cells (Fig. 4e) .
To control whether systematic arrangement and shaping of adhesive islets are required to affect fibroblast adhesion and myofibroblast activation, we next produced irregular patterns of similarly sized adhesive features. Silicone was stenciled with FN, collagen, and sNAG through polycarbonate filters exhibiting randomly arranged pores with diameters of 2, 5 and 10 mm (Fig. 5a ).
Fibroblasts effectively attached and spread by forming FAs with the protein islets and were activated by TGF-b1 to become a-SMApositive myofibroblasts (~60%) even on small islet patterns (Fig. 5bed) . Collectively, these data demonstrate that regular arrays of 4 Â 2 mm adhesive islands allow for fibroblast attachment and proliferation by simultaneously suppressing a-SMA organization into contractile fibers. This effect was not achieved using uncoated substrates that were found to be non-adhesive, and larger microarrays and completely coated substrates that lead to substantial myofibroblast activation.
Microarrays of protein islets suppress monocyte/macrophage fusion into giant foam cells
Foreign body reactions to silicone implants are initiated by the recruitment and activation of macrophages to the implant surface. One characteristic of an active inflammatory response and precondition for the development of fibrosis is fusion of monocytes/macrophages into giant multi-nucleated cells during the foreign body reaction [24, 25] . To evaluate the effect of micropatterns on macrophage activation, we seeded F4/80-positive murine macrophages onto uncoated, fully coated, and 4 Â 2 mm FN pattern-coated silicone strips for 7 days in the presence of lipopolysaccharide (LPS). In contrast to fibroblastic cells, macrophages did not form discrete vinculin-positive FAs (unpublished data). Macrophages adhered with 2-fold higher numbers to fully FN coated (387 ± 15 nuclei/mm 2 ) and uncoated silicone substrates (453 ± 18 nuclei/mm 2 ) compared with 4 Â 2 mm micro-patterned surfaces (220 ± 17 nuclei/mm 2 ) (Fig. 6a, b) . Formation of multinuclear giant foam cells was highest on full FN-coated silicone (86 ± 3% multi-nucleated cells) and lowest on micro-patterned silicone (20 ± 4% multi-nucleated cells) (Fig. 6a, c) . No differences were observed between FN and collagen coating (unpublished data).
Implant micropatterns reduce foreign body reactions and fibrotic capsule formation in vivo
Micropatterns of 4 Â 2 mm islets of collagen, FN, and sNAG all promoted adhesion of cultured fibroblasts to silicone substrates and suppressed myofibroblast and macrophage activation. To evaluate whether this anti-fibrotic effect is relevant in vivo, we subcutaneously implanted respectively coated/patterned silicone strips subcutaneously to the dorsum of rats. As protein we used collagen type I that is available in medical grade due to its weak antigenicity and immunogenicity [26] . Uncoated silicone substrates were used to represent the current clinical standard for implant coating, and completely collagen coated silicone implants served as positive experimental controls. When the body reaction to protein patterned implants was histologically analyzed after 30 days (Fig. 7a) , accumulation of ECM and cells around micro-patterned implants was substantially lower than in uncoated and fully coated controls (Fig. 7bed) . The center of capsules formed around uncoated silicone implants was particularly rich in multi-nucleated cells (6-fold compared to both other groups) which were identified as foreign-body giant cells (Fig. 7b, inset ) that stained positive for the macrophage marker CD68 (Fig. 8a, green, arrows) . Multinucleated giant cells were virtually absent from capsules forming around micro-patterned and fully coated implants ( Fig. 7b ) with only few CD68-positive macrophages localizing to the implantetissue interface (Fig. 8a, green, arrows) . The collagenous ECM organization and cellularity of capsules formed around micropatterned capsules was morphologically similar to the adjacent normal connective tissue (Fig. 7a, b) . In contrast, collagen coated and uncoated implants were characterized by accumulation of dense ECM fibers and high cell density (Fig. 7b) . To quantify the thickness of the collagenous capsule wall surrounding the implant we performed morphometric image analysis on cross-sections of excised capsules with associated tissue that were stained with Masson's Trichrome (Fig. 7c) . The capsule wall diameter around micro-patterned implants (37 ± 10 mm) was 3-times smaller than the collagen rich layer around uncoated implants (50 ± 19 mm) and 1.5-times smaller than around fully coated implants (90 ± 37 mm) (Fig. 7c) . Collagenous capsules always form around implants to various degrees; it is the accumulation of contractile myofibroblasts that ultimately leads to ECM contracture and necessitates recurrent surgery [27, 28] . Immunostaining of tissue cross-sections for a-SMA revealed that myofibroblasts accumulated to different degrees depending on the implant coating, being lowest in the micropatterned group (Fig. 8a) . To quantify myofibroblast occurrence, cross-sections were immunohistochemically stained for a-SMA and the thickness of the a-SMA-positive layer was measured from the implant surface (Fig. 7d) . The a-SMA positive layer at the surface of micro-patterned implants was significantly thinner (20 ± 7 mm) than around completely coated implants (45 ± 18 mm) and uncoated implants (50 ± 21 mm) (Fig. 7d) . This layer comprised almost 90% of the total wall thickness around completely coated implants but only~50% of the capsule wall around micro-patterned and uncoated implants. Analyzing the staining intensities of collagen and a-SMA delivered similar results than those obtained from measuring layer thickness (Fig. 8b) . Collagen density in the capsule was~2-times lower (20 ± 4%) compared with capsules formed around completely coated silicone (46.3 ± 19%) and~3-times lower than non-coated silicone implants (62.7 ± 15%) (Fig. 8b) . The density of a-SMA at the surface of micro-patterned implants was generally low (22.3 ± 8%), in contrast to the capsules of completely coated implants (46.6 ± 6%) and non-coated implants (56 15%). Collagen and a-SMA densities in the capsule layer were plotted against each other to provide a 'capsule contracture index' (Fig. 8b) to show that 4 Â 2 mm micropattern significantly reduce capsule formation and accumulation of contractile myofibroblasts in vivo.
Discussion
A variety of different medical implants are produced with a shell that is impermeable to cells, most often silicone or polyurethane, which comes into contact with the patient's host tissue. Since adverse reactions to silicone arise at the implant surface, recent fundamental and clinical research focus on silicone shell engineering to improve implant biointegration. In our study, we developed a novel protein micropattern coating that improved silicone implant biointegration by promoting: 1) decreased inflammatory foreign body reaction, 2) controlled cell and fibroblast adhesion, and 3) decreased activation of a-SMA-positive myofibroblasts (Fig. 9) .
The formation of collagen-rich capsules around implants is part of the normal wound healing response of inflammation, cell proliferation, and tissue remodeling [3] . Material charge, wettability, and topographic structure have a substantial impact on the adhesive properties of silicone implants [29] . If implant materials are non-adhesive for host cells and ECM, dead space develops between the tissue and the implant surface, allowing non-specific absorption of blood plasma and serum proteins [3] . This chemical microenvironment attracts and activates macrophages as important sources of pro-fibrotic cytokines, leading to fibroblast recruitment and myofibroblast activation [30] . Conversely, adhesive implants appear to partially reduce macrophage activation and fusion into multi-nucleated giant cells during the foreign body reaction [29] . Consistently, low-adhesive untreated silicones in our study produced higher numbers of multi-nucleated giant cells compared to adhesive fully coated substrates in vivo and in vitro. It is currently unclear, how 4 Â 2 micro-patterned silicone surfaces further suppress giant cell formation to~20% of fully coated silicone. However, other studies have shown that dictating macrophage shape and spreading by controlling substrate topography is able to control the activation state of macrophages [31, 32] . Despite reducing the macrophage-dominated foreign-body reaction, highly adhesive silicone surfaces, such as the fully protein coated silicones in our study, trigger severe fibrotic capsule covalently coated with collagen type I over the whole surface (collagen coated), and microstencilled with arrays of 4 Â 2 mm adhesion patterns (4Â2 collagen). Silicone pads were then implanted subcutaneously on the dorsum of rats for 30 days before animals were sacrificed and the peri-silicone tissue was analyzed by histology. (a) H&E staining was used to provide overall morphology and cellularity of the subcutaneous implant with its ECM-and cell-rich capsule, the underlying muscle layer, and the overlaying dermis and epidermis. (b) Capsules forming around non-coated implants were populated by a higher numbers of multi-nucleated giant cells (outlined by dotted lines and arrows in higher magnification inset) compared to completely coated and micro-patterned implants as seen in H&E stained tissue sections and respective quantification giant multinuclear cells. (c) Masson's trichrome staining was used to detect collagen rich ECM (blue) and to quantify the thickness of the collagenous fibrotic layer from the implant surface. (d) Tissue sections were immunohistochemically stained for a-SMA (brown) to identify myofibroblast accumulation and the myofibroblast layer thickness was quantified from the implant surface by image analysis. Scale bars: (a): 1 mm, (bed): 100 mm. Quantifications were performed on at least 8 animals, each with four experimental conditions. Mean values are shown ± SD; *p 0.01, two-tailed paired Student's t-test. formation and contracture [23] . In these conditions, activation of myofibroblasts is the main driver for fibrogenesis and can occur even at reduced levels of inflammation. A plethora of studies demonstrated the spontaneous activation of various precursor cells to attain the myofibroblast phenotype on pathophysiologically stiff polymer substrates [18,33e36] . Despite being macroscopically deformable, implant silicone materials have a 100e1000-times higher elastic modulus (~500e3000 kPa) than the connective tissue of of recipient tissues like skin dermis [37, 38] (~0.5e5 kPa). Myofibroblast activation is effectively suppressed by reducing mechanical stress, either acting as extracellular stress in tissue strain and stiffness or intracellularly as cell contraction [11] . Development of intracellular stress is limited by the amount of force that fibroblasts can transmit to any material, which can be modulated by controlling substrate adhesiveness, deformability (elastic modulus), or topography to promote cell spreading [36,39e41] . In a previous study, we have shown that controlling the size of individual FAs, i.e. the efficacy of cell mechanosensing and force transmission, controls intracellular stress and myofibroblast activation [17] . This effect was largely independent from island density as shown by modulating island spacing from 2 to 6 mm.
However, a regular arrangement of FAs is pivotal because fibroblasts are able to extend single FAs over multiple small islands that are closer than~1.5 mm and accommodate cell morphology to exert maximum tension. The size of FAs is linearly related to the force they can transmit and sustain with a stress of~5.5 nN/mm 2 for classical FAs and~12.5 nN/mm 2 for myofibroblast supermature FAs [17, 42] . Hence, restricting FAs size by micropatterning will limit the tension developed by stress fibers that are anchored to the ECM at FAs. We have previously shown that high intracellular stress, in turn, is required to promote myofibroblast activation and incorporation of a-SMA into stress fibers [17, 21, 37] . Once myofibroblasts are formed, they will contribute to collagen accumulation and fibrotic capsule contraction around the implant. For the present study, we have selected micropattern arrays of 4 Â 2 mm sized adhesive structures that were shown to arrest fibroblasts in a noncontractile, non-fibrotic state even on GPa-stiff plastic and glass surfaces [17] . Transfer of these patterns to silicone implants was sufficient to supress myofibroblast activation by 2e3-fold compared to fully protein coated silicone pro-fibrotic conditions in culture and animal experiments. Generation of protein patterns with micron-resolution on glass and plastic is effective using microcontact printing [43e45]. However, to achieve good transfer, protein adhesion to the silicone over the whole surface (collagen coated), and microstencilled with arrays of 4 Â 2 mm adhesion patterns (4 Â 2 collagen). Silicone pads were then implanted subcutaneously on the dorsum of rats for 30 days before animals were sacrificed and paraffin sections of the peri-silicone tissue were produced. (a) Sections were immunofluorescence-stained for myofibroblast marker a-SMA (red), macrophage marker CD68 (green), and nuclei (blue) and images were produced in two different magnifications. Arrows point to CD68-positive inflammatory cells. Scale bars: 100 mm. (b) To calculate a "fibrotic index", slides were immunohistochemically stained for either collagenous ECM (Masson's Trichrome) or myofibroblasts (a-SMA). The respective staining intensities were normalized to the total stained area using image analysis and plotted as collagen density over a-SMA density.
Quantification was performed on at least 8 animals, each with four experimental conditions per experimental condition. Mean values are shown ± SD; *p 0.01, two-tailed paired Student's t-test.
rubber stamp has to be lower than the affinity to the substrate. This is difficult to achieve when both substrate and stamp are fabricated with the same silicone material and similar mechanical properties. We here solved this critical limitation of former techniques by developing an innovative microstencil method to covalently attach soluble adhesive compounds, including proteins onto silicone substrates with~1 mm resolution. Using pliable pyrelene stencils, we are further able accommodate curved and three-dimensionally complex surfaces. One open remaining question is whether the anti-fibrotic effect of the novel micropattern observed after 1 week in culture and after 4 weeks in animal experiments will last in longterm clinical applications. Preliminary results at one year show a stable tissue reaction around the implants (not shown) and a number of studies suggest that early activation of myofibroblasts already sets the stage for a persistent fibrotic reaction. This effect is partly due to the specific chemical and mechanical property of myofibroblast-derived ECM [46, 47] and partly due to the ability of myofibroblast populations to retain and propagate once acquired features in a changed environment [48] .
In summary, our results suggest that uncoated silicone induces the formation of a fibrotic capsule containing a high number of contractile myofibroblasts, probably as a result of lack of cell adhesion and macrophage activation via foreign body reaction. Completely coated silicone surfaces have similar fibrotic effects because unrestricted cell attachment sites cause high myofibroblast development possibly via intracellular mechanical forces development on the implant surface during healing. The identified novel methods to generate micropatterns on silicone substrates suppressed the dead space and decreased foreign body reaction, while also having an anti-fibrotic effect due to the specific design (4 Â 2 mm) of the adhesion sites.
Conclusions
In conclusion, we have developed a novel strategy to make silicone surfaces more biocompatible. This micro-patterning approach has several advantages compared to previously proposed techniques including the possibility to being applied to several different biomaterials without changing their macroscopic properties and being based entirely on clinically used substrates. These experimental results will hopefully set the stage for clinical translation in the near future.
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